Similar articles

• [A case of curatively resected gastric cancer through an effective response to chemotherapy].

  Ema T, Arai K, Maeda Y, Iwasaki Y, Katayanagi S, Takahashi K, Yamaguchi T, Takahashi T. Ema T, et al. Gan To Kagaku Ryoho. 2004 Jun;31(6):925-8. Gan To Kagaku Ryoho. 2004. PMID: 15222114 Japanese.
• Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

  Fazio N, Biffi R, Curigliano G, Lorizzo K, Zampino MG, de Braud F, Chiappa A, Roth A, Goldhirsch A. Fazio N, et al. J Natl Cancer Inst. 2007 Sep 5;99(17):1345-6; author reply 1346-7. doi: 10.1093/jnci/djm092. Epub 2007 Aug 28. J Natl Cancer Inst. 2007. PMID: 17728219 No abstract available.
• Adjuvant therapy for gastric cancer: how negative results can help patients.

  Ellenberg SS, Sun W. Ellenberg SS, et al. J Natl Cancer Inst. 2007 Apr 18;99(8):580-2. doi: 10.1093/jnci/djk162. J Natl Cancer Inst. 2007. PMID: 17440152 No abstract available.
• [Effect of antifolates and folates on the antineoplastic action of fluoropyrimidines].

  Graczyk J. Graczyk J. Postepy Hig Med Dosw. 1992;46(2):143-58. Postepy Hig Med Dosw. 1992. PMID: 1470578 Review. Polish.
• [The present situation of neoadjuvant therapy for head and neck carcinoma].

  Rikimaru F, Tomita K. Rikimaru F, et al. Gan To Kagaku Ryoho. 2007 Oct;34(10):1535-7. Gan To Kagaku Ryoho. 2007. PMID: 17940367 Review. Japanese.